The methods of analysis for three-category-outcome longitudinal data vary. Some analyses use polytomous logistic regression; others use the ordered nature of the outcome data to create new variables where binary logistic regression is utilized. We have examined a continuous-time Markov chain approach for trinomial-outcome longitudinal data. This technique is unique in that it allows researchers to examine the time to transition across stages. The primary assumption of a Markov chain is that the probability of the future outcome depends only on the current outcome and not on past outcomes. Previous research on continuous-time Markov models was utilized to express and estimate the relationship of a longitudinal trinomial-outcome with independ...
We consider longitudinal studies with binary outcomes that are measured repeatedly on subjects over ...
We consider longitudinal studies with binary outcomes that are measured repeatedly on subjects over ...
From the clinical setting, the capability for clinicians to predict prognosis of disease progression...
The methods of analysis for three-category-outcome longitudinal data vary. Some analyses use polytom...
In this dissertation, we propose a continuous-time Markov chain model to examine the longitudinal da...
In this dissertation, we propose a continuous-time Markov chain model to examine the longitudinal da...
Properly understanding the course of disease, particularly the transition rate from one disease stag...
Properly understanding the course of disease, particularly the transition rate from one disease stag...
Continuous time Markov chain (CTMC) models are widely used to study the progression of a chronic dis...
Continuous time Markov chain (CTMC) models are widely used to study the progression of a chronic dis...
Continuous time Markov chain (CTMC) models are widely used to study the progression of a chronic dis...
Continuous time Markov chain (CTMC) models are widely used to study the progression of a chronic dis...
A patient-reported outcome (PRO) is a type of outcome reported directly from patients, and it has be...
Collecting multiple binary responses over time is very common in the longitudinal studies for biomed...
Collecting multiple binary responses over time is very common in the longitudinal studies for biomed...
We consider longitudinal studies with binary outcomes that are measured repeatedly on subjects over ...
We consider longitudinal studies with binary outcomes that are measured repeatedly on subjects over ...
From the clinical setting, the capability for clinicians to predict prognosis of disease progression...
The methods of analysis for three-category-outcome longitudinal data vary. Some analyses use polytom...
In this dissertation, we propose a continuous-time Markov chain model to examine the longitudinal da...
In this dissertation, we propose a continuous-time Markov chain model to examine the longitudinal da...
Properly understanding the course of disease, particularly the transition rate from one disease stag...
Properly understanding the course of disease, particularly the transition rate from one disease stag...
Continuous time Markov chain (CTMC) models are widely used to study the progression of a chronic dis...
Continuous time Markov chain (CTMC) models are widely used to study the progression of a chronic dis...
Continuous time Markov chain (CTMC) models are widely used to study the progression of a chronic dis...
Continuous time Markov chain (CTMC) models are widely used to study the progression of a chronic dis...
A patient-reported outcome (PRO) is a type of outcome reported directly from patients, and it has be...
Collecting multiple binary responses over time is very common in the longitudinal studies for biomed...
Collecting multiple binary responses over time is very common in the longitudinal studies for biomed...
We consider longitudinal studies with binary outcomes that are measured repeatedly on subjects over ...
We consider longitudinal studies with binary outcomes that are measured repeatedly on subjects over ...
From the clinical setting, the capability for clinicians to predict prognosis of disease progression...